Company intelligence / Profile preview

Steri-Med Pharma

Upton, Quebec, Canada

Ownership: Private
Employees: ~266
Development stage: Other

Overview

Steri-Med Pharma is a Canadian commercial-stage pharmaceutical company specializing in the manufacturing and development of sterile ophthalmic products, including erythromycin ophthalmic ointments. The company has recently expanded its production capacity and secured new international contracts, reflecting growing demand for its products. Steri-Med Pharma is actively developing a pipeline of first-to-market generic products.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Steri-Med Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Steri-Med Pharma.

Explore the full profile